Suppr超能文献

利用四维F-FDG PET/CT的葡萄糖代谢率诊断心脏结节病

Diagnosis of cardiac sarcoidosis using glucose metabolic rate from four-dimensional F-FDG PET/CT.

作者信息

Shirai Yurie, Nagao Michinobu, Inoue Akihiro, Yamamoto Atsushi, Kaneko Koichiro, Sakai Akiko, Suzuki Atsushi, Yamaguchi Junichi, Sakai Shuji

机构信息

Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.

出版信息

Ann Nucl Med. 2025 Jun 14. doi: 10.1007/s12149-025-02070-3.

Abstract

OBJECTIVE

F-Fludeoxyglucose (FDG) PET/CT is an effective tool for detecting active cardiac sarcoidosis (CS), but often has difficulty distinguishing CS lesions from physiological myocardial accumulation. We investigated the potential of the glucose metabolic rate (MR, mg/min/100mL) from four-dimensional FDG PET/CT in distinguishing between CS and physiological accumulation. Additionally, we compared CS delineation between MR and standardized uptake value (SUV).

METHODS

A total of 192 individuals with CS or suspected CS who underwent four-dimensional FDG PET/CT after 18 h fasting was enrolled. Ultimately, 45 individuals with CS and 14 patients with physiological accumulation, with SUV ≥ 2.7 accumulation in the left ventricular myocardium, were analyzed. The SUV, MR, and the ratio of MR to SUV (MR/SUV) were calculated for each lesion with SUV ≥ 2.7 using data acquired between 30 and 50 min on four-dimensional FDG PET/CT. In the CS group, lesion-to-normal myocardium contrast ratios on MR and SUV images were compared.

RESULTS

A total of 127 lesions from 45 individuals with CS and 43 physiological accumulations from 14 individuals were analyzed. The SUV, MR and MR/SUV for CS lesions were significantly lower than those for physiological accumulations (SUV, 4.26±1.35 vs. 6.06±3.28; MR, 1.91 ± 1.02 vs. 3.78 ± 2.11; MR/SUV, 0.43 ± 0.14 vs. 0.63 ± 0.14; p < 0.0001). Receiver operating characteristic analysis revealed that the ability to discriminate CS lesions from physiological accumulations yielded areas under the curves of 0.656, 0.808, and 0.849; sensitivities of 68, 76, and 73%; and specificities of 61, 72, and 84%, for SUV 4.525, MR 2.41, and MR/SUV 0.518. In the CS group, the contrast ratio of lesions was significantly greater on MR images than on SUV images (6.36 ± 6.17 vs. 2.54 ± 1.03, p < 0.0001).

CONCLUSIONS

MR from four-dimensional FDG PET/CT is a useful quantitative measure to distinguish CS lesions from physiological accumulation and enables better visualization of CS lesion contrast than SUV.

摘要

目的

氟脱氧葡萄糖(FDG)PET/CT是检测活动性心脏结节病(CS)的有效工具,但在区分CS病变与生理性心肌摄取方面常常存在困难。我们研究了四维FDG PET/CT的葡萄糖代谢率(MR,mg/min/100mL)在区分CS与生理性摄取方面的潜力。此外,我们比较了MR和标准化摄取值(SUV)在CS病变勾画方面的差异。

方法

共纳入192例CS患者或疑似CS患者,这些患者在禁食18小时后接受了四维FDG PET/CT检查。最终,分析了45例CS患者和14例生理性摄取患者,其左心室心肌SUV≥2.7。使用四维FDG PET/CT在30至50分钟之间获取的数据,计算每个SUV≥2.7的病变的SUV、MR以及MR与SUV的比值(MR/SUV)。在CS组中,比较了MR和SUV图像上病变与正常心肌的对比率。

结果

共分析了45例CS患者的127个病变和14例患者的43个生理性摄取。CS病变的SUV、MR和MR/SUV显著低于生理性摄取(SUV,4.26±1.35对6.06±3.28;MR,1.91±1.02对3.78±2.11;MR/SUV,0.43±0.14对0.63±0.14;p<0.0001)。受试者操作特征分析显示,区分CS病变与生理性摄取的能力在SUV为4.525、MR为2.41、MR/SUV为0.518时,曲线下面积分别为0.656、0.808和0.849;敏感度分别为68%、76%和73%;特异度分别为61%、72%和84%。在CS组中,MR图像上病变的对比率显著高于SUV图像(6.36±6.17对2.54±1.03,p<0.0001)。

结论

四维FDG PET/CT的MR是区分CS病变与生理性摄取的有用定量指标,与SUV相比,能更好地显示CS病变的对比。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验